Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

How to advance from minimally invasive coronary artery bypass grafting to totally endoscopic coronary bypass grafting: challenges in Europe versus United States of America

M. Algoet, T. Melvin, S. Cerny, J. Bonatti, S. Singh, T. Folliguet, P. Modi, U. Franke, M. Gianoli, A. Agnino, F. Casselman, W. Oosterlinck

. 2024 ; 13 (5) : 397-408. [pub] 20240923

Status not-indexed Language English Country China

Document type Journal Article, Review

Robotic coronary and intra-cardiac surgery has been available for more than 25 years. In this period, multiple studies have demonstrated the beneficial effects of robotic surgery over conventional open surgery. Throughout the years, technical developments have enabled us to perform totally endoscopic coronary artery bypass (TECAB) grafting. But these techniques remained in the hands of a small group of pioneers because of a lack of structured training programs and the absence of long-term results at that time. Currently, a renewed interest and a wide dispersion of robotic platforms, thanks to use of robotics in other disciplines, has led to an exponential increase in robotic cardiac centers both in Europe and USA. Nonetheless, this increase was slowed down in Europe as a result of the uncertainty introduced by the implementation of a revised regulatory framework for medical devices [Regulation 2017/745, 'Medical Device Regulation' ('MDR')]. The MDR was introduced with the goal of increasing patient safety and supporting innovation. Implementing the MDR has proven to be exceptionally challenging and risks to the supply of essential devices have been identified. Changes to both regulatory and market dynamics led to a circumstance where the only available robotic platform for cardiac surgery decided to cease marketing of essential accessories for conducting surgery. This resulted in the disappearance of dedicated tools such as the Endowrist stabilizer, essential for TECAB, and the atrial retractor which is essential for intra-cardiac surgery. In the mean-time, further clinical evidence was published demonstrating the superiority of robotic cardiac surgery over other minimally invasive approaches. This has demonstrated the need to better define the clinical evidence requirements for regulatory purposes to ensure that dedicated tools for evidence-based interventions in robotic coronary surgery remain available such that TECAB can continue in Europe.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002454
003      
CZ-PrNML
005      
20250123101914.0
007      
ta
008      
250117s2024 cc f 000 0|eng||
009      
AR
024    7_
$a 10.21037/acs-2023-rcabg-0210 $2 doi
035    __
$a (PubMed)39434975
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a cc
100    1_
$a Algoet, Michiel $u Department of Cardiovascular Sciences, Research Unit of Cardiac Surgery, KU Leuven, Leuven, Belgium
245    10
$a How to advance from minimally invasive coronary artery bypass grafting to totally endoscopic coronary bypass grafting: challenges in Europe versus United States of America / $c M. Algoet, T. Melvin, S. Cerny, J. Bonatti, S. Singh, T. Folliguet, P. Modi, U. Franke, M. Gianoli, A. Agnino, F. Casselman, W. Oosterlinck
520    9_
$a Robotic coronary and intra-cardiac surgery has been available for more than 25 years. In this period, multiple studies have demonstrated the beneficial effects of robotic surgery over conventional open surgery. Throughout the years, technical developments have enabled us to perform totally endoscopic coronary artery bypass (TECAB) grafting. But these techniques remained in the hands of a small group of pioneers because of a lack of structured training programs and the absence of long-term results at that time. Currently, a renewed interest and a wide dispersion of robotic platforms, thanks to use of robotics in other disciplines, has led to an exponential increase in robotic cardiac centers both in Europe and USA. Nonetheless, this increase was slowed down in Europe as a result of the uncertainty introduced by the implementation of a revised regulatory framework for medical devices [Regulation 2017/745, 'Medical Device Regulation' ('MDR')]. The MDR was introduced with the goal of increasing patient safety and supporting innovation. Implementing the MDR has proven to be exceptionally challenging and risks to the supply of essential devices have been identified. Changes to both regulatory and market dynamics led to a circumstance where the only available robotic platform for cardiac surgery decided to cease marketing of essential accessories for conducting surgery. This resulted in the disappearance of dedicated tools such as the Endowrist stabilizer, essential for TECAB, and the atrial retractor which is essential for intra-cardiac surgery. In the mean-time, further clinical evidence was published demonstrating the superiority of robotic cardiac surgery over other minimally invasive approaches. This has demonstrated the need to better define the clinical evidence requirements for regulatory purposes to ensure that dedicated tools for evidence-based interventions in robotic coronary surgery remain available such that TECAB can continue in Europe.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Melvin, Tom $u School of Medicine, Trinity College Dublin, Dublin, Ireland
700    1_
$a Cerny, Stepan $u Cardiothoracic Surgery Department, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Bonatti, Johannes $u Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
700    1_
$a Singh, Sandeep $u ISALA Hospital, Zwolle, The Netherlands
700    1_
$a Folliguet, Thierry $u Department of Cardio-Thoracic Surgery, University Hospital Henri-Mondor, Assistance Publique-Hopitaux de Paris Créteil, Paris, France
700    1_
$a Modi, Paul $u The Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK
700    1_
$a Franke, Ulrich $u Department of Cardiovascular Surgery, Robert Bosch Hospital, Stuttgart, Germany
700    1_
$a Gianoli, Monica $u Department of Cardiac Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands
700    1_
$a Agnino, Alfonso $u Department of Cardiac Surgery, Humanitas Gavazzeni, Bergamo, Italy
700    1_
$a Casselman, Filip $u Cardiovascular Center Aalst, OLV Clinic Aalst, Aalst, Belgium
700    1_
$a Oosterlinck, Wouter $u Department of Cardiovascular Sciences, Research Unit of Cardiac Surgery, KU Leuven, Leuven, Belgium
773    0_
$w MED00201247 $t Annals of cardiothoracic surgery $x 2225-319X $g Roč. 13, č. 5 (2024), s. 397-408
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39434975 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101908 $b ABA008
999    __
$a ok $b bmc $g 2254584 $s 1238457
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 13 $c 5 $d 397-408 $e 20240923 $i 2225-319X $m Annals of cardiothoracic surgery $n Ann Cardiothorac Surg $x MED00201247
LZP    __
$a Pubmed-20250117

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...